Lenzings, Heiligenkreuz

Lenzing's Heiligenkreuz Deadline Looms as Berenberg Trims Target and Goldman Cuts Stake

Published on 11/21/2026 at 22:01 | Editorial boerse-global.de
Lenzing shares slid 5.9% to EUR 9.56, near their 52-week low, as Berenberg cut its target to EUR 13.50 and a Heiligenkreuz sale review continues.
Lenzing's Heiligenkreuz Deadline Looms as Berenberg Trims Target and Goldman Cuts Stake Illustration mit AI erstellt.

Lenzing shares slid 5.9% on Friday to EUR 9.56, closing just above their 52-week low, as heightened risk aversion following the international selloff in technology stocks spilled over into Viennese industrial names, dpa-AFX reported. The retreat puts a sharper focus on whether the fiber maker's underlying earnings power can carry the stock without a broader market recovery — and on a pair of site decisions that will shape the answer.

The number that matters most

Management has guided for adjusted EBITDA of EUR 430 million to EUR 460 million in 2026, and that range is the yardstick investors should use to gauge operating progress. It does not, however, settle whether Lenzing is profitable at the bottom line; net income after tax must be judged separately.

The distinction is not academic. Over the first nine months of 2026, Lenzing generated EUR 353 million in adjusted EBITDA on revenue of EUR 1.93 billion — yet posted a loss of EUR 130.3 million after tax. A positive result before depreciation and amortization is no proof of a return to profit.

Writedowns feed into the per-share estimate

Berenberg made that gap explicit on Thursday, folding a EUR 136 million impairment at Grimsby and Heiligenkreuz into its 2026 earnings-per-share forecast. Analyst Sebastian Bray cut his price target to EUR 13.50 from EUR 17.00 while keeping a "Hold" rating. The move illustrates why the adjusted EBITDA guidance and the EPS expectation cannot be treated as interchangeable.

Should investors sell immediately? Or is it worth buying Lenzing?

Separately, Goldman Sachs reported a reduced voting position in Lenzing of 4.90%, down from 5.86%, according to a correction published Thursday that names NN Group as the shareholder and Goldman Sachs as the entity required to notify.

Two sites, two different decisions

Lenzing is reviewing several non-binding purchase offers for its Heiligenkreuz plant in southern Burgenland, according to Der Standard. Clarity on whether an economically viable sale can be reached is expected by the end of 2026; failing that, closure is scheduled for the end of the first quarter of 2027. The offers under review are not yet a sale, and the shutdown date is the alternative to a deal, not its outcome.

At Mobile, Alabama, the company has announced a EUR 27 million investment to expand specialty fiber capacity for nonwovens, part of a EUR 50 million program for the nonwovens business. The two sites thus point in opposite directions — a potential exit in Heiligenkreuz, an expansion in Mobile. For investors, a fulfilled earnings forecast combined with a Heiligenkreuz solution would say more than the Alabama announcement on its own, since the pledged investment is not yet a contribution to results.

What to watch into year-end

The next concrete checkpoint is the Heiligenkreuz decision: whether the review of non-binding bids produces a deal or whether the planned closure moves to the fore. Should a sale take shape, it would reduce uncertainty around the site. A sale would not, however, substitute for operating earnings if Lenzing misses its guidance range — and if the forecast falls short, the reported losses would carry added weight, forcing investors to reassess their expectations for the core business rather than just the site question.

As long as the operating forecast holds, the location issue can be assessed separately from current earnings momentum. Whether the stock finds firmer footing after Friday's decline rests, above all, on adjusted EBITDA.

Ad

Lenzing Stock: New Analysis - 21 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZINGS | boerse | 70543535 |